GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Elevance Health Inc (WBO:ELV) » Definitions » Research & Development

Elevance Health (WBO:ELV) Research & Development : €0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Elevance Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Elevance Health's Research & Development for the three months ended in Mar. 2024 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

Elevance Health Research & Development Historical Data

The historical data trend for Elevance Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elevance Health Research & Development Chart

Elevance Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Elevance Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Elevance Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health  (WBO:ELV) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Elevance Health Research & Development Related Terms

Thank you for viewing the detailed overview of Elevance Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Elevance Health (WBO:ELV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Elevance Health Inc (WBO:ELV) » Definitions » Research & Development
Comparable Companies
CI CVS CNC HUM MOH OSCR ALHC CLOV NEUE MRAI UNH SZSE:000503 BSP:ODPV3 NSE:MEDIASSIST BJSE:870656 BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG PFHO
Traded in Other Exchanges
ELV:USA ELV:Mexico A58:Germany
Address
220 Virginia Avenue, Indianapolis, IN, USA, 46204
Website
https://www.elevancehealth.com
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 48 million medical members as of June 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.